Finance
Biopharma company announces revenues of $1.4 million
Published in Obesity and Diabetes Week, December 19th, 2005
The $925,000 increase in revenues for the quarter compared to the prior year period was due to sponsored research and license fee revenue from a collaboration entered into in June 2005 with Merck & Co., Inc. to research, develop and commercialize novel small molecule therapeutics with potential to treat several metabolic diseases, including type 2 diabetes, hyperlipidemia and obesity.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Control
Gender differences to insulin response and resistance susceptibilities are prevalent - Diabetes Pathogenesis
LXR activation decreases blood glucose but does not affect hepatic insulin sensitivity - Disease Associations
Obesity negatively impacts health-related utility equally for diabetics and nondiabetics - Obesity Pathogenesis
Adiponectin levels depend on adipocyte differentiation and high molar mass serum components - Obesity Therapy
Overproducing leptin receptors in fat cells may play role in blocking weight gain - Adipose Tissue
Nnat increases CREB phosphorylation and enhances adipogenic differentiation in rat model - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
